There's real potential to double your $7,000 TFSA contribution over time with a combination of price gains and dividend income from quality dividend-paying stocks.
The Schwab U.S. Dividend Equity ETF and the Vanguard Total Stock Market ETF are both terrific funds. But one has the edge in terms of long-term growth potential.
Angel Oak UltraShort Income ETF offers a higher-yielding alternative to money market funds, with a diversified portfolio of short-duration fixed income and securitized credit.
The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.84%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.35%. June E-mini S&P futures (ESM26 ) rose +0.79%, and June...
TELUS delivered record free cash flow and Canada's best churn rate. Meanwhile, BCE is rebuilding. Which Canadian telecom stock is a better buy for TFSA investors.
Thomson Reuters stock is down 57% from its peak and offers a growing dividend. Here is why long-term investors may want to take a closer look right now.
PRA Group (NASDAQ:PRAA) reported a stronger first quarter of 2026, with management pointing to higher cash collections, continued growth in its U.S. legal collections channel and steady performance in Europe as key drivers of the period.
President and Chief Executive Officer Martin Sjolund said the
Praxis Precision Medicines (NASDAQ:PRAX) said it is preparing for two potential U.S. product launches while advancing several late-stage clinical programs, as management outlined first-quarter 2026 results and pipeline updates on the company’s earnings call.
President and Chief Executive Officer Ma
Perdoceo Education (NASDAQ:PRDO) reported stronger-than-expected first-quarter 2026 results, with management citing enrollment gains, high student retention and continued investments in marketing, admissions and technology across its academic institutions.
President and Chief Executive Officer Todd
BlackLine (NASDAQ:BL) shareholders approved all four proposals presented at the company’s 2026 annual stockholders meeting, including a stockholder proposal calling for the elimination of the company’s classified board structure, according to preliminary voting results announced during the meeting.
Pulse Biosciences (NASDAQ:PLSE) said it is sharpening its focus on its nanosecond pulsed field ablation platform for atrial fibrillation after reporting first-quarter 2026 results and highlighting new clinical data from its cardiac catheter program.
On the company’s earnings call, Co-Chairman and C
Playtika (NASDAQ:PLTK) reported a stronger-than-expected start to 2026, driven by rapid growth at its SuperPlay studio, record direct-to-consumer revenue and improving stability in parts of its legacy portfolio, executives said on the company’s first-quarter earnings call.
The mobile gaming company
The Pennant Group (NASDAQ:PNTG) reported a sharp increase in first-quarter 2026 revenue and adjusted earnings as growth in its home health and hospice business, continued senior living margin improvement and ongoing integration of newly added operations helped drive results.
Chief Executive Officer
Power Integrations (NASDAQ:POWI) reported first-quarter revenue of $108.3 million, up 3% from a year earlier and 5% sequentially, as growth in industrial markets offset weaker year-over-year consumer sales tied to last year’s appliance-related inventory pull-ins.
CEO Jen Lloyd said the company deli
Palomar (NASDAQ:PLMR) reported a strong start to 2026, with management highlighting broad-based premium growth, continued underwriting profitability and an increased full-year adjusted net income outlook during the company’s first-quarter earnings call.
Chairman and Chief Executive Officer Mac Arms
Moderna shares rally as investors bet on recent Hantavirus outbreak accelerating the biotech firm’s path to profitability. But there are ample reasons to avoid buying MRNA stock today.
